NasdaqCM - Nasdaq Real Time Price USD
Microbot Medical Inc. (MBOT)
As of 3:27 PM EDT. Market Open.
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Expense
9,788.0000
10,136.0000
13,437.0000
11,357.0000
9,089.0000
Operating Income
-9,788.0000
-10,136.0000
-13,437.0000
-11,357.0000
-9,089.0000
Net Non Operating Interest Income Expense
239.0000
283.0000
54.0000
44.0000
-80.0000
Other Income Expense
--
-887.0000
215.0000
44.0000
--
Pretax Income
-10,436.0000
-10,740.0000
-13,168.0000
-11,313.0000
-9,169.0000
Net Income Common Stockholders
-10,436.0000
-10,740.0000
-13,168.0000
-11,313.0000
-9,169.0000
Diluted NI Available to Com Stockholders
-10,436.0000
-10,740.0000
-13,168.0000
-11,313.0000
-9,169.0000
Basic EPS
-0.78
-1.05
-1.81
-1.59
-1.29
Diluted EPS
-0.78
-1.05
-1.81
-1.59
-1.29
Basic Average Shares
13,120.9610
10,199.9840
7,260.3440
7,108.1330
7,117.7470
Diluted Average Shares
13,120.9610
10,199.9840
7,260.3440
7,108.1330
7,117.7470
Total Operating Income as Reported
-9,507.0000
-9,855.0000
-13,281.0000
-11,357.0000
-9,089.0000
Total Expenses
9,788.0000
10,136.0000
13,437.0000
11,357.0000
9,089.0000
Net Income from Continuing & Discontinued Operation
-10,436.0000
-10,740.0000
-13,168.0000
-11,313.0000
-9,169.0000
Normalized Income
-9,549.0000
-9,853.0000
-13,383.0000
-11,357.0000
-9,169.0000
Interest Income
239.0000
283.0000
54.0000
--
--
Interest Expense
--
--
--
--
80.0000
Net Interest Income
239.0000
283.0000
54.0000
44.0000
-80.0000
EBIT
-9,788.0000
-10,136.0000
-13,437.0000
-11,357.0000
-9,089.0000
EBITDA
-9,691.0000
-10,030.0000
-13,335.0000
-11,281.0000
-9,021.0000
Reconciled Depreciation
97.0000
106.0000
102.0000
76.0000
68.0000
Net Income from Continuing Operation Net Minority Interest
-10,436.0000
-10,740.0000
-13,168.0000
-11,313.0000
-9,169.0000
Total Unusual Items Excluding Goodwill
-887.0000
-887.0000
215.0000
44.0000
--
Total Unusual Items
-887.0000
-887.0000
215.0000
44.0000
--
Normalized EBITDA
-8,804.0000
-9,143.0000
-13,550.0000
-11,325.0000
-9,021.0000
12/31/2020 - 3/25/1992
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
POAI Predictive Oncology Inc.
0.6900
-3.82%
STSS Sharps Technology, Inc.
2.8300
-2.41%
ZJYL Jin Medical International Ltd.
1.9900
-0.50%
EKSO Ekso Bionics Holdings, Inc.
0.8700
+1.64%
OSUR OraSure Technologies, Inc.
4.1650
+2.46%
LUCY Innovative Eyewear, Inc.
7.62
-7.07%
AVGR Avinger, Inc.
0.7970
+2.18%
PLSE Pulse Biosciences, Inc.
14.58
-16.35%
BOEUF Bonesupport Holding AB (publ)
32.46
0.00%
NEPH Nephros, Inc.
1.4767
+1.84%